SCHEMBL18815129

SCHEMBL18815129

C=C1c2ccccc2SCc2c(Cl)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PIM1 P11309 1/20 0.40
▸ MAOB P27338 1/20 0.36
▸ MAPT P10636 3/20 0.33
▸ POLB P06746 2/20 0.33
▸ HSD17B3 P37058 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ ADRA2C P18825 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796296 0.80 MAOB (0.49) MEN1KMT2AALOX15TDP1PIM1
SCHEMBL18873161 0.73 ALDH1A1 (0.49) MEN1KMT2AALOX15TDP1MAPT
SCHEMBL15395749 0.72 MEN1 (0.41) MEN1KMT2AALOX15TDP1MAOB
SCHEMBL20014743 0.69 HSD17B3 (0.40) MEN1KMT2AALOX15TDP1PIM1
SCHEMBL10196640 0.68 MEN1 (0.43) MEN1KMT2AALOX15TDP1MAOB
SCHEMBL2601352 0.67 NOTUM (0.39) MEN1KMT2APIM1MAOBNOTUM
SCHEMBL18796516 0.67 ALDH1A1 (0.37) MEN1KMT2AALOX15TDP1PIM1
SCHEMBL18796426 0.66 ALDH1A1 (0.41) TDP1PIM1MAOBMAPTPOLB
SCHEMBL16385845 0.66 HTR2C (0.39) TDP1PIM1MAPTPOLBHSD17B3
SCHEMBL8860333 0.66 HSD17B3 (0.47) TDP1PIM1MAPTPOLBHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017072341-A1 PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2017-05-04 — — WO disclosed
Send feedback